Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07501962

Effect of Intraluminal Administration of Menthol Solution During Colonoscopy on Colonic Spasm and Adenoma Detection Rate

Effect of Intraluminal Administration of Menthol Solution During Colonoscopy on Colonic Spasm and Adenoma Detection Rate: An Efficacy and Safety Study

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
440 (estimated)
Sponsor
The First Affiliated Hospital of Zhengzhou University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

In recent years, with increasing research into antispasmodic agents, topical antispasmodics have attracted considerable attention due to their direct action on the gastrointestinal mucosa and relatively low incidence of adverse reactions. Menthol, a natural terpenoid compound found in peppermint oil, has been confirmed by numerous studies to possess spasmolytic properties. Existing evidence indicates that menthol relaxes intestinal smooth muscle and alleviates spasm symptoms by antagonizing L-type calcium channels on the smooth muscle cell membrane, thereby reducing calcium influx. Furthermore, it exhibits local analgesic effects and can attenuate visceral hypersensitivity. Some studies suggest that oral or topical administration of peppermint oil preparations may improve intestinal spasm during colonoscopy, highlighting its potential utility in digestive endoscopy procedures. Nevertheless, current research on the spasmolytic efficacy and safety of menthol solution when administered via endoscopic irrigation during colonoscopy remains limited, and high-quality clinical trials are urgently needed for validation. This study aims to investigate the effectiveness and safety of menthol solution in relieving intestinal spasm, thereby providing scientific evidence for optimizing colonoscopy procedures.

Conditions

Interventions

TypeNameDescription
DRUGEndoscopic irrigation was performed using a 0.1% menthol solution combined with simethicone.Preparation method: Normal saline was used as the solvent. Menthol cyclodextrin inclusion complex (containing 7.3% menthol) was accurately weighed at 6.85 g and dissolved in 500 ml of normal saline to prepare a 0.1% menthol solution. After complete dissolution, 5 g of simethicone was added to form an aqueous suspension.
DRUGEndoscopic irrigation was performed using an aqueous suspension prepared with simethicone and normal saline.Preparation method: 5 g of simethicone was added to 500 ml of normal saline to form the aqueous suspension.

Timeline

Start date
2026-04-01
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2026-03-30
Last updated
2026-03-30

Source: ClinicalTrials.gov record NCT07501962. Inclusion in this directory is not an endorsement.